Genetically transitional disease: a new concept in genomic medicine
Traditional classification of genetic diseases as monogenic and polygenic has lagged far
behind scientific progress. In this opinion article, we propose and define a new terminology …
behind scientific progress. In this opinion article, we propose and define a new terminology …
Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …
Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer
Cancer is one of the most widespread and severe diseases with a huge mortality rate. In
recent years, the second-leading mortality rate of any cancer globally has been breast …
recent years, the second-leading mortality rate of any cancer globally has been breast …
[HTML][HTML] Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking …
L Incorvaia, A Perez, C Marchetti, C Brando… - Cancer Treatment …, 2023 - Elsevier
Breast cancer susceptibility gene 1 (BRCA1) and breast cancer susceptibility gene 2
(BRCA2) deleterious variants were the first and, still today, the main biomarkers of poly …
(BRCA2) deleterious variants were the first and, still today, the main biomarkers of poly …
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
ABSTRACT Formyl peptide receptor-1 (FPR1) is a pathogen recognition receptor involved in
the detection of bacteria, in the control of inflammation, as well as in cancer …
the detection of bacteria, in the control of inflammation, as well as in cancer …
Individualizing Breast Cancer Risk Assessment in Clinical Practice
AE Cyr, K Kennard - Surgical Oncology Clinics, 2023 - surgonc.theclinics.com
Breast cancer (BC) is the most common malignancy in American women.*, 1 Mortality has
declined, in part because screening detects cancers at an early stage. 2 For most women …
declined, in part because screening detects cancers at an early stage. 2 For most women …
Surgical options for patients with early-stage breast cancer and pathogenic germline variants: an oncologist perspectives
H Abdel-Razeq - Frontiers in Oncology, 2023 - frontiersin.org
Breast cancer continues to be the most common cancer diagnosed among women
worldwide. Family history of breast cancer is frequently encountered, and 5-15% of patients …
worldwide. Family history of breast cancer is frequently encountered, and 5-15% of patients …
Two unrelated cases with biallelic CHEK2 variants:a novel condition with constitutional chromosomal instability?
I Bottillo, E Savino, S Majore, C Mulargia… - European Journal of …, 2023 - nature.com
Constitutional heterozygous mutations in CHEK2 gene have been associated with
hereditary cancer risk. To date, only a few homozygous CHEK2 mutations have been …
hereditary cancer risk. To date, only a few homozygous CHEK2 mutations have been …
Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes
A Calabrese, C von Arx, AA Tafuti, M Pensabene… - Cancer Treatment …, 2024 - Elsevier
The detection of germline pathogenic variants (gPVs) in BRCA1/2 and other breast cancer
(BC) genes is rising exponentially thanks to the advent of multi-gene panel testing. This …
(BC) genes is rising exponentially thanks to the advent of multi-gene panel testing. This …
High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive
J Wilczyński, E Paradowska, M Wilczyński - Biomedicines, 2024 - mdpi.com
High-grade serous ovarian cancer (HGSOC) is the most lethal tumor of the female genital
tract. Despite extensive studies and the identification of some precursor lesions like serous …
tract. Despite extensive studies and the identification of some precursor lesions like serous …